For each patient, we also showed the risk in the well-known high-penetrance cancer risk alleles BRCA1 and BRCA2 with respect to other moderate-penetrance alleles including PALB2, CHEK2, ATM, BARD1, RAD51D, RAD51C and BRIP1 (Figure 4B). This evidence concerns the gene PALB2 and cancer.